Twitter

Archive for April 19th, 2012


in Patients With Lymphoma Failed to Standard Therapy

Condition :   Lymphoma Intervention :   Drug: CKD-581 Sponsors :   Chong Kun Dang Pharmaceutical;   Chong Kun Dang Pharmaceutical Active, not recruiting – verified April 2012

Read More...

PRevention of End Stage Kidney Disease by Darbepoetin Alfa In Chronic Kidney Disease Patients With nondiabeTic Kidney Disease

Conditions :   Chronic Kidney Disease;   Diabetes Interventions :   Drug: darbepoetin alfa;   Drug: darbepoetin alfa Sponsors :   Translational Research Informatics Center, Kobe, Hyogo, Japan;   Translational Research Informatics Center, Kobe, Hyogo, Japan;   Showa University School of Medicine Recruiting – verified April 2012

Read More...

ERCP-based Sampling of Indeterminate Bile Duct Strictures

Condition :   Indeterminate Bile Duct Stricture Interventions :   Procedure: Multiple brushings;   Procedure: Multimodality tissue sampling Sponsors :   Indiana University;   Indiana University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Recruiting – verified April 2012

Read More...

Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer

Condition :   Pancreatic Ductal Adenocarcinoma Intervention :   Drug: Doxorubicin-EMCH Sponsors :   CytRx;   CytRx Not yet recruiting – verified April 2012

Read More...

National Breast Cancer and Lymphedema Registry

Conditions :   Breast Cancer;   Lymphedema Intervention :   Sponsors :   Stanford University;   Stanley Rockson Recruiting – verified April 2012

Read More...

Therapeutic Effects of Traditional Chinese Medicine, Shen-Mai San in Cancer Patient Undergoing Chemotherapy or Radiotherapy

Condition :   Cancer Patients Undergoing Chemotherapy or Radiotherapy Interventions :   Drug: Shen-Mai San;   Drug: Starch Sponsors :   Changhua Christian Hospital;   Changhua Christian Hospital;   Committee on Chinese Medicine and Pharmacy Active, not recruiting – verified April 2012

Read More...

ARQ 197 Plus Erlotinib in Patient With Locally Advanced or Metastatic EGFR Mutation-positive Non-small-cell Lung Cancer

Condition :   Non-small-cell Lung Cancer Intervention :   Drug: ARQ 197 Sponsors :   Kyowa Hakko Kirin Company, Limited;   Kyowa Hakko Kirin Company, Limited Not yet recruiting – verified April 2012

Read More...

Phase Ib Trial of Folate Binding Protein Vaccine in Ovarian Cancer

Conditions :   Ovarian Cancer;   Endometrial Cancer Interventions :   Biological: E39 peptide vaccine;   Other: Clinical tracking for disease progression/recurrence Sponsors :   San Antonio Military Medical Center;   COL George Peoples, MD, FACS Recruiting – verified April 2012

Read More...

Head to Head Study Epi proColon and FIT

Condition :   Colorectal Cancer Intervention :   Sponsors :   Epigenomics, Inc;   Epigenomics, Inc Recruiting – verified April 2012

Read More...

Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer

Condition :   Lung Neoplasms Intervention :   Sponsors :   University of Colorado, Denver;   University of Colorado, Denver Recruiting – verified April 2012

Read More...